UNSPSC 41202016: Cytomegalovirus serological reagents

In this classification, Cytomegalovirus serological reagents are devices used in test to identify specific Cytomegalovirus antibodies in serum. US FDA regulates Cytomegalovirus serological reagents under 21 CFR 866.3175 and under FDA product code GQH.

UNSPSC 41202016 Cytomegalovirus serological reagents is a Commodity code that encompasses HIV, Syphilis, and Hepatitis testing kits, reagents, and related diagnostic supplies procured by state and local public health departments, correctional agencies, and municipal health services to support disease surveillance, screening, and clinical laboratory operations. The recent opportunities solicited under this code show that state and local governments are buying rapid HIV test kits, 4th-generation multiplex screening assays (HIV/Syphilis/Hepatitis combination panels), Abbott-manufactured reagent systems with instrument support, and specimen collection and testing services that include immunoassay screening with LC/MS/MS or GC/MS confirmation protocols. Issuing bodies include state health departments (Illinois Department of Public Health), county correctional and community supervision agencies (Collin County Community Supervision and Corrections Department), municipal public health programs (City of Austin), and state criminal justice departments (Texas Department of Criminal Justice). Procurement vehicles range from competitive ITBs and RFPs to sole-source emergency purchases driven by equipment lock-in and critical public health continuity needs.

Recent activity concentrates in Texas and Illinois. The Illinois Department of Public Health issued a five-year IFB for Hepatitis/HIV/Syphilis 4th-generation multiplex screening assays and instrumentation in Jackson County (due March 16, 2026) and two emergency sole-source procurements for Abbott HIV/Syphilis reagents at the Carbondale Laboratory totaling $38,079.50 (awarded February–May 2026). Collin County Community Supervision and Corrections Department in Texas solicited offender specimen collection and drug testing services via RFP 2026-327 (response due July 23, 2026) with an estimated annual value of $600,000 over five years, encompassing two collection sites, immunoassay screening with confirmatory testing, and oral fluid and hair testing methodologies. The City of Austin issued IFB 9100AAM1023 for rapid HIV test kits—specifically Abbott Determine HIV 1/2 Ag/Ab Combo kits and controls—with bids due July 17, 2026. The Texas Department of Criminal Justice posted an RFP for forensic analysis services including serology testing (RFP 696-IG-26-P034, proposals due May 13, 2026). Sole-source awards to Abbott Laboratories on Abbott proprietary systems reflect the manufacturer-locked nature of multiplex platform contracts, while competitive opportunities for test kits and specimen collection services remain open to qualified vendors meeting SAMHSA, state licensure, and accreditation standards.